Abubakar Sadiq Yakubu is a researcher in Pharmaceutical and Medicinal Chemistry with academic qualifications in Pharmaceutical and Medicinal Chemistry, Industrial Chemistry, and Science Laboratory Technology. He holds an MSc in Pharmaceutical and Medicinal Chemistry, a BSc in Industrial Chemistry, and an HND in Science Laboratory Technology. He is currently pursuing a PhD in Pharmaceutical Chemistry, specializing in Computer-Aided Drug Design (CADD), with a research focus on discovering potential therapeutic agents for Alzheimer's disease. His research interests include computational drug design, molecular modelling, molecular docking, molecular dynamics simulations, structure-based drug design, pharmacokinetic and toxicity prediction, and the synthesis and biological evaluation of bioactive compounds. His previous research involved the computational design and investigation of diphenylquinoline derivatives as potential antidepressant agents targeting monoamine oxidase A (MAO-A) and the serotonin transporter (SERT). He is also interested in anticancer drug discovery, particularly targeting proteins such as O6-methylguanine-DNA methyltransferase (MGMT). He has contributed to several scientific publications and delivered a workshop at Kaduna State University on in-silico drug repurposing and molecular docking as part of the AIDR Workshop. He is committed to advancing pharmaceutical research through computational chemistry, medicinal chemistry, and drug discovery approaches.